Outcomes in interstitial lung diseases (ILDs)

R. Carbone, F. Montanaro, G. Bottino (Genoa, Italy; Locarno, Switzerland)

Source: Annual Congress 2005 - Advancements in diffuse parenchymal lung disease
Session: Advancements in diffuse parenchymal lung disease
Session type: Poster Discussion
Number: 1807
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Carbone, F. Montanaro, G. Bottino (Genoa, Italy; Locarno, Switzerland). Outcomes in interstitial lung diseases (ILDs). Eur Respir J 2005; 26: Suppl. 49, 1807

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PG11 Acute interstitial lung diseases (ILD)
Source: Milan 2017 - Educational material
Year: 2017

Delay in diagnosis of interstitial lung diseases (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018



Interstitial lung diseases
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013


Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015


Interstitial lung diseases
Source: ERS Course 2015
Year: 2015

Interstitial lung diseases
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012

Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014


Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD)
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016


Comorbidities in interstitial lung diseases
Source: Eur Respir Rev 2017; 26: 160027
Year: 2017



OSA with intertitial lung diseases
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016